Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

Proteus Digital Health is collaborating on a pipeline of digital, oral solid-dosage drugs for various therapies, including cardiovascular and oncology drugs, based on its first NDA, which used ingestible sensors in an antipsychotic treatment.

Proteus is Extending the Reach of the Digital Pill

The new platform is expected to speed up cell line development.

Sanofi Buys Berkeley Lights’ Cell Line Platform

Johnson & Johnson’s Janssen partners with Bristol-Myers Squibb to advance next-generation therapies for cardiovascular diseases.

J&J, BMS Team Up on Cardiovascular Therapies

The agency has granted breakthrough therapy designation to Roche’s hemophilia therapy for treating hemophilia A in patients without factor VIII inhibitors.

FDA Grants Roche Breakthrough Therapy Designation on Hemophilia Drug

Hallie Forcinio is packing editor for Pharmaceutical Technology and Pharmaceutical Technology Europe, editorhal@sbcglobal.net.

INTERPHEX presents advances in pharmaceutical container filling, robotic handling, and serialization. 

New Equipment and Software Meet Needs for Fill/Finish, Serialization, and Data Traceability

Sartorius Stedim Biotech will supply equipment for Penn State’s new Fermentation Facility in the university’s Center of Excellence in Industrial Biotechnology. 

Sartorius Stedim Biotech and Penn State University Announce Biotechnology Partnership

The new facility, to be built in Toronto, Canada, will significantly increase capacity for pediatric and booster vaccines. 

Sanofi to Invest Roughly $430 Million in Canadian Vaccine Facility

New filling and inspection machines and new containers and closures for injectable drugs will be on display at INTERPHEX 2018.

Parenteral Packaging Innovations

The biopharmaceutical firm has chosen Rhode Island as the site of its next-generation biomanufacturing plant, which will offer flexibility, speed, and efficiency.

Amgen to Build Next-Generation Biomanufacturing Plant

The new 300,000-square-foot facility is considered the largest dedicated cell and gene therapy manufacturing facility with fully integrated services.